Compare AANJANEYA LIFECARE with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS UNICHEM LAB DR. DATSONS LABS/
UNICHEM LAB
 
P/E (TTM) x -10.9 -47.2 - View Chart
P/BV x 0.2 1.2 14.0% View Chart
Dividend Yield % 0.0 1.2 -  

Financials

 DR. DATSONS LABS   UNICHEM LAB
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
UNICHEM LAB
Mar-19
DR. DATSONS LABS/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs126292 43.0%   
Low Rs31182 17.0%   
Sales per share (Unadj.) Rs133.0167.7 79.3%  
Earnings per share (Unadj.) Rs0.2-3.6 -4.2%  
Cash flow per share (Unadj.) Rs6.65.9 111.2%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %01.7 0.0%  
Book value per share (Unadj.) Rs128.8372.3 34.6%  
Shares outstanding (eoy) m31.6670.38 45.0%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.61.4 41.6%   
Avg P/E ratio x516.1-65.3 -790.7%  
P/CF ratio (eoy) x11.839.9 29.7%  
Price / Book Value ratio x0.60.6 95.4%  
Dividend payout %0-110.2 0.0%   
Avg Mkt Cap Rs m2,47716,680 14.9%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m562,393 2.3%   
Avg. sales/employee Rs ThNM4,535.2-  
Avg. wages/employee Rs ThNM919.8-  
Avg. net profit/employee Rs ThNM-98.2-  
INCOME DATA
Net Sales Rs m4,21111,801 35.7%  
Other income Rs m79984 8.0%   
Total revenues Rs m4,28912,785 33.5%   
Gross profit Rs m569-835 -68.1%  
Depreciation Rs m204674 30.3%   
Interest Rs m43075 572.1%   
Profit before tax Rs m13-600 -2.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-21 -257.1%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-343 -1.8%   
Profit after tax Rs m5-256 -1.9%  
Gross profit margin %13.5-7.1 -190.9%  
Effective tax rate %48.057.3 83.9%   
Net profit margin %0.1-2.2 -5.3%  
BALANCE SHEET DATA
Current assets Rs m6,85220,384 33.6%   
Current liabilities Rs m6,7115,029 133.4%   
Net working cap to sales %3.3130.1 2.6%  
Current ratio x1.04.1 25.2%  
Inventory Days Days161105 153.5%  
Debtors Days Days318135 236.1%  
Net fixed assets Rs m3,6739,023 40.7%   
Share capital Rs m317141 224.9%   
"Free" reserves Rs m3,76126,058 14.4%   
Net worth Rs m4,07826,199 15.6%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63331,496 40.1%  
Interest coverage x1.0-7.0 -14.8%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.30.4 89.0%   
Return on assets %3.4-0.6 -601.4%  
Return on equity %0.1-1.0 -12.1%  
Return on capital %7.7-2.0 -383.8%  
Exports to sales %22.969.4 33.0%   
Imports to sales %14.30-   
Exports (fob) Rs m9648,188 11.8%   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9648,188 11.8%   
Fx outflow Rs m607596 101.9%   
Net fx Rs m3577,592 4.7%   
CASH FLOW
From Operations Rs m1,345-3,278 -41.0%  
From Investments Rs m-2,256-2,860 78.9%  
From Financial Activity Rs m-1,200-24 4,957.9%  
Net Cashflow Rs m-2,111-4,690 45.0%  

Share Holding

Indian Promoters % 4.5 50.1 9.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 15.1 -  
FIIs % 1.4 3.0 45.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 31.7 296.8%  
Shareholders   20,807 20,176 103.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   SHASUN PHARMA  WYETH  ABBOTT INDIA  SUVEN LIFE SCIENCES  DR. REDDYS LAB  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Nifty is Weak but Smallcaps Can Outperform(Momentum Moves)

The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS